[1]
“COVID-19 AND INTELLECTUAL PROPERTY LAW: COMPULSORY LICENSING AND THE ACCESS TO COVID-19 TREATMENT ”, De Legibus, no. 1, p. 16, Oct. 2021, doi: 10.53456/dlb.vi1.7556.